Dewpoint Therapeutics shared new research showing that DPTX3230 restored TDP-43 nuclear function across translational models of ALS.
The findings mark a step forward in the company’s research into potential treatments for neurodegenerative disease.
Dewpoint Therapeutics shared new research showing that DPTX3230 restored TDP-43 nuclear function across translational models of ALS.
The findings mark a step forward in the company’s research into potential treatments for neurodegenerative disease.
